Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Core EBITDA Margin

    Back to All Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Margin(%) -532.26-89.65

What is the latest Core EBITDA Margin ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Core EBITDA Margin ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -532.26 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-532.26
Mar2023-89.65

How is Core EBITDA Margin of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Core EBITDA Margin % Change
Mar2024 -532.26
Negative
Mar2023 -89.65 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Core EBITDA Margin ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹5,182.3 Cr -3.7% -4.5% -26.6% Stock Analytics
SYNGENE INTERNATIONAL ₹26,172.9 Cr -2% 1.2% -4.9% Stock Analytics
SAGILITY INDIA ₹19,235.6 Cr 2.4% -11.2% NA Stock Analytics
LATENT VIEW ANALYTICS ₹8,336.3 Cr -2.7% -3.7% -22.4% Stock Analytics
JUST DIAL ₹7,488.2 Cr -4.4% -6.4% -13.4% Stock Analytics
AWFIS SPACE SOLUTIONS ₹4,695.1 Cr -1.4% 1.4% 43.8% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-3.7%

-4.5%

-26.6%

SENSEX

-1%

-0.9%

6.7%


You may also like the below Video Courses